Publicaciones en colaboración con investigadores/as de Mayo Clinic (42)

2024

  1. OMERACT systemic lupus erythematosus domain survey

    Seminars in Arthritis and Rheumatism, Vol. 68

  2. Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH

    Liver International

2022

  1. De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management - Guidelines from the ILTS-SETH Consensus Conference

    Transplantation, Vol. 106, Núm. 1, pp. E30-E45

  2. Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution

    Clinical and Translational Oncology, Vol. 24, Núm. 2, pp. 319-330

  3. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

    Nature Reviews Gastroenterology and Hepatology, Vol. 19, Núm. 9, pp. 585-604

  4. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  5. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Clinical Response to Procedural Stroke Following Carotid Endarterectomy: A Delphi Consensus Study

    European Journal of Vascular and Endovascular Surgery, Vol. 62, Núm. 3, pp. 350-357

  2. Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

    Annals of Neurology, Vol. 89, Núm. 6, pp. 1088-1098

  3. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models

    Journal of Hepatology, Vol. 74, Núm. 2, pp. 394-406

2020

  1. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

  2. Corrigendum to ‘Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia’ (European Journal of Vascular & Endovascular Surgery (2019) 58(1S) (S1–S109.e33), (S1078588419303806), (10.1016/j.ejvs.2019.05.006))

    European Journal of Vascular and Endovascular Surgery

  3. Corrigendum to “Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia” [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1–109>] (European Journal of Vascular & Endovascular Surgery (2019) 58(1S) (S1–S109.e33), (S1078588419303806), (10.1016/j.ejvs.2019.05.006))

    European Journal of Vascular and Endovascular Surgery

  4. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia

    Nature cancer, Vol. 1, Núm. 3, pp. 329-344

2019

  1. AVIATOR: An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm

    Journal of Thoracic and Cardiovascular Surgery, Vol. 157, Núm. 6, pp. 2202-2211.e7

  2. Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR

    Seminars in Thoracic and Cardiovascular Surgery, Vol. 31, Núm. 4, pp. 643-649

  3. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

    European Journal of Vascular and Endovascular Surgery, Vol. 58, Núm. 1, pp. S1-S109.e33

2017

  1. Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210

  2. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150

  3. Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015

    The Lancet, Vol. 390, Núm. 10091, pp. 231-266